Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_1
2
40%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Completed2
Enrolling by invitation1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (66.7%)
Phase 31 (33.3%)

Trials by Status

enrolling_by_invitation120%
recruiting120%
not_yet_recruiting120%
completed240%

Recent Activity

1 active trials
Showing 5 of 5
not_yet_recruitingphase_3

Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation

NCT07759453
recruiting

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

NCT07268560
enrolling_by_invitation

Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria

NCT07176247
completedphase_1

Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

NCT04486625
completedphase_1

Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.

NCT04973826

Clinical Trials (5)

Showing 5 of 5 trials
NCT07759453Phase 3

Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation

Not Yet Recruiting
NCT07268560

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Recruiting
NCT07176247

Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria

Enrolling By Invitation
NCT04486625Phase 1

Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

Completed
NCT04973826Phase 1

Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5